Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma
暂无分享,去创建一个
M. Okada | T. Hyodo | K. Tomita | A. Takeda | K. Numata | Takahisa Eriguchi | Hiromi Nihonmatsu | Kenichiro Tago | M. Nakano
[1] O. Matsui,et al. Pathology and images of radiation-induced hepatitis: a review article , 2018, Japanese Journal of Radiology.
[2] R. Ma,et al. Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma: imaging evaluation post treatment. , 2018, The British journal of radiology.
[3] M. Kudo,et al. Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function , 2017, Liver Cancer.
[4] Jieun Kim,et al. Radiation-induced liver disease: current understanding and future perspectives , 2017, Experimental &Molecular Medicine.
[5] E. Kunieda,et al. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation , 2016, Cancer.
[6] Manabu Watanabe,et al. Evaluation of contrast-enhanced ultrasonography for hepatocellular carcinoma prior to and following stereotactic body radiation therapy using the CyberKnife® system: A preliminary report , 2015, Oncology letters.
[7] K. Awai,et al. Clinical utility of gadoxetate disodium-enhanced hepatic MRI for stereotactic body radiotherapy of hepatocellular carcinoma , 2015, Japanese Journal of Radiology.
[8] B. Sangro,et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] E. Kunieda,et al. Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA. , 2014, International journal of radiation oncology, biology, physics.
[10] E. Kunieda,et al. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma , 2014, Journal of gastroenterology and hepatology.
[11] Sang‐wook Lee,et al. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters , 2013, Radiation oncology.
[12] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[13] E. Kunieda,et al. CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function. , 2010, The British journal of radiology.
[14] G. van Kaick,et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. , 2003, International journal of radiation oncology, biology, physics.
[15] G. McDonald,et al. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). , 2002, Seminars in liver disease.